Effect of the COVID-19 pandemic on acute stroke reperfusion therapy: data from the Lyon Stroke Center Network
- PDF / 997,786 Bytes
- 6 Pages / 595.276 x 790.866 pts Page_size
- 15 Downloads / 168 Views
ORIGINAL COMMUNICATION
Effect of the COVID‑19 pandemic on acute stroke reperfusion therapy: data from the Lyon Stroke Center Network Cécile Plumereau1,2 · Tae‑Hee Cho2,3 · Marielle Buisson4 · Camille Amaz4 · Matteo Cappucci5 · Laurent Derex2,6 · Elodie Ong2,3 · Julia Fontaine2 · Lucie Rascle2 · Roberto Riva5 · David Schiavo1 · Axel Benhamed1 · Marion Douplat1 · Thomas Bony1 · Karim Tazarourte1,6 · Célia Tuttle5 · Omer Faruk Eker5 · Yves Berthezène5,7 · Michel Ovize3,4 · Norbert Nighoghossian2,3 · Laura Mechtouff2,3 Received: 24 July 2020 / Revised: 26 August 2020 / Accepted: 29 August 2020 © Springer-Verlag GmbH Germany, part of Springer Nature 2020
Abstract Background The coronavirus disease 2019 (COVID-19) pandemic would have particularly affected acute stroke care. However, its impact is clearly inherent to the local stroke network conditions. We aimed to assess the impact of COVID-19 pandemic on acute stroke care in the Lyon comprehensive stroke center during this period. Methods We conducted a prospective data collection of patients with acute ischemic stroke (AIS) treated with intravenous thrombolysis (IVT) and/or mechanical thrombectomy (MT) during the COVID-19 period (from 29/02/2020 to 10/05/2020) and a control period (from 29/02/2019 to 10/05/2019). The volume of reperfusion therapies and pre and intra-hospital delays were compared during both periods. Results A total of 208 patients were included. The volume of IVT significantly decreased during the COVID-period [55 (54.5%) vs 74 (69.2%); p = 0.03]. The volume of MT remains stable over the two periods [72 (71.3%) vs 65 (60.8%); p = 0.14], but the door-to-groin puncture time increased in patients transferred for MT (237 [187–339] vs 210 [163–260]; p
Data Loading...
